I'll be quick.
When we look at a generation of international tolerances, it really does seem as though there are very few products that regulators don't agree on or come up with different approaches on. It seems to me that it's analogous to the pharmaceutical system, in which there really are very few drugs that are controversial in terms of their effects on humans. I don't know if the neonicotinoid issue is representative of the broader package of products that are registered for crops.